Loading…
Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer
[Display omitted]
Saved in:
| Published in: | Clinical lung cancer 2018-11, Vol.19 (6), p.e843-e847 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c356t-79694a1981327a6a521dc7a68acc6abcbc59ec298c21f15522016346456051043 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c356t-79694a1981327a6a521dc7a68acc6abcbc59ec298c21f15522016346456051043 |
| container_end_page | e847 |
| container_issue | 6 |
| container_start_page | e843 |
| container_title | Clinical lung cancer |
| container_volume | 19 |
| creator | Iijima, Yuki Hirotsu, Yosuke Mochizuki, Hitoshi Amemiya, Kenji Oyama, Toshio Uchida, Yoshinori Kobayashi, Yoichi Tsutsui, Toshiharu Kakizaki, Yumiko Miyashita, Yoshihiro Omata, Masao |
| description | [Display omitted] |
| doi_str_mv | 10.1016/j.cllc.2018.07.002 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2090331204</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525730418301694</els_id><sourcerecordid>2090331204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-79694a1981327a6a521dc7a68acc6abcbc59ec298c21f15522016346456051043</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSMEoqXwAiyQl2wS_JM4icRmlP5QaSpQO4ildefGmfEosVvbqdTn4gVxOoUlK1_5fvfY95ws-8howSiTXw4FjiMWnLKmoHVBKX-VnbJWNDmVLX2d6opXeS1oeZK9C-GQACkYf5udCMo4LwU9zX6fP1mYDJJuD3anAwHbk3M_7_Jr28-oe3KnR43ROEvcQG51MCGCjaQbnU24sQTID4hGp7tfJu7JxdXlbX4zR4hpeNVr6xA8GusmIJs9RLLCh9n41NzULb0hz-giv7y88WDD4PyU2tGRuwnGMe_0OJL1bHekA4vav8_eDDAG_eHlPMt-Xl5sum_5-vvVdbda5ygqGfO6lW0JrG2Y4DVIqDjrMRUNIErY4harViNvG-RsYFXFk5FSlLKsJK0YLcVZ9vmoe-_dw6xDVJMJmD4DVrs5KE5bKpKhzyg_ouhdCF4P6t6bCfyTYlQtYamDWsJSS1iK1iplkYY-vejP27Twv5G_6STg6xHQactHo70KmIxOqST_MKremf_p_wEKxqUL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2090331204</pqid></control><display><type>article</type><title>Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer</title><source>ScienceDirect Freedom Collection</source><creator>Iijima, Yuki ; Hirotsu, Yosuke ; Mochizuki, Hitoshi ; Amemiya, Kenji ; Oyama, Toshio ; Uchida, Yoshinori ; Kobayashi, Yoichi ; Tsutsui, Toshiharu ; Kakizaki, Yumiko ; Miyashita, Yoshihiro ; Omata, Masao</creator><creatorcontrib>Iijima, Yuki ; Hirotsu, Yosuke ; Mochizuki, Hitoshi ; Amemiya, Kenji ; Oyama, Toshio ; Uchida, Yoshinori ; Kobayashi, Yoichi ; Tsutsui, Toshiharu ; Kakizaki, Yumiko ; Miyashita, Yoshihiro ; Omata, Masao</creatorcontrib><description>[Display omitted]</description><identifier>ISSN: 1525-7304</identifier><identifier>EISSN: 1938-0690</identifier><identifier>DOI: 10.1016/j.cllc.2018.07.002</identifier><identifier>PMID: 30122430</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenocarcinoma - drug therapy ; Adenocarcinoma - genetics ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Carboplatin - therapeutic use ; Cell Transformation, Neoplastic ; Clone Cells ; Drug Resistance, Neoplasm - genetics ; Drug Substitution ; ErbB Receptors - genetics ; Etoposide - therapeutic use ; Ex 19 del ; Female ; Humans ; Lung cancer ; Lung Neoplasms - drug therapy ; Lung Neoplasms - genetics ; Middle Aged ; Mutation - genetics ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Osimertinib ; Remission Induction ; SCLC transformation ; Small Cell Lung Carcinoma - drug therapy ; Small Cell Lung Carcinoma - genetics ; T790M</subject><ispartof>Clinical lung cancer, 2018-11, Vol.19 (6), p.e843-e847</ispartof><rights>2018 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-79694a1981327a6a521dc7a68acc6abcbc59ec298c21f15522016346456051043</citedby><cites>FETCH-LOGICAL-c356t-79694a1981327a6a521dc7a68acc6abcbc59ec298c21f15522016346456051043</cites><orcidid>0000-0001-8345-9551</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30122430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iijima, Yuki</creatorcontrib><creatorcontrib>Hirotsu, Yosuke</creatorcontrib><creatorcontrib>Mochizuki, Hitoshi</creatorcontrib><creatorcontrib>Amemiya, Kenji</creatorcontrib><creatorcontrib>Oyama, Toshio</creatorcontrib><creatorcontrib>Uchida, Yoshinori</creatorcontrib><creatorcontrib>Kobayashi, Yoichi</creatorcontrib><creatorcontrib>Tsutsui, Toshiharu</creatorcontrib><creatorcontrib>Kakizaki, Yumiko</creatorcontrib><creatorcontrib>Miyashita, Yoshihiro</creatorcontrib><creatorcontrib>Omata, Masao</creatorcontrib><title>Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer</title><title>Clinical lung cancer</title><addtitle>Clin Lung Cancer</addtitle><description>[Display omitted]</description><subject>Adenocarcinoma - drug therapy</subject><subject>Adenocarcinoma - genetics</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Carboplatin - therapeutic use</subject><subject>Cell Transformation, Neoplastic</subject><subject>Clone Cells</subject><subject>Drug Resistance, Neoplasm - genetics</subject><subject>Drug Substitution</subject><subject>ErbB Receptors - genetics</subject><subject>Etoposide - therapeutic use</subject><subject>Ex 19 del</subject><subject>Female</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - genetics</subject><subject>Middle Aged</subject><subject>Mutation - genetics</subject><subject>Neoplasm Recurrence, Local</subject><subject>Neoplasm Staging</subject><subject>Osimertinib</subject><subject>Remission Induction</subject><subject>SCLC transformation</subject><subject>Small Cell Lung Carcinoma - drug therapy</subject><subject>Small Cell Lung Carcinoma - genetics</subject><subject>T790M</subject><issn>1525-7304</issn><issn>1938-0690</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhSMEoqXwAiyQl2wS_JM4icRmlP5QaSpQO4ildefGmfEosVvbqdTn4gVxOoUlK1_5fvfY95ws-8howSiTXw4FjiMWnLKmoHVBKX-VnbJWNDmVLX2d6opXeS1oeZK9C-GQACkYf5udCMo4LwU9zX6fP1mYDJJuD3anAwHbk3M_7_Jr28-oe3KnR43ROEvcQG51MCGCjaQbnU24sQTID4hGp7tfJu7JxdXlbX4zR4hpeNVr6xA8GusmIJs9RLLCh9n41NzULb0hz-giv7y88WDD4PyU2tGRuwnGMe_0OJL1bHekA4vav8_eDDAG_eHlPMt-Xl5sum_5-vvVdbda5ygqGfO6lW0JrG2Y4DVIqDjrMRUNIErY4harViNvG-RsYFXFk5FSlLKsJK0YLcVZ9vmoe-_dw6xDVJMJmD4DVrs5KE5bKpKhzyg_ouhdCF4P6t6bCfyTYlQtYamDWsJSS1iK1iplkYY-vejP27Twv5G_6STg6xHQactHo70KmIxOqST_MKremf_p_wEKxqUL</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Iijima, Yuki</creator><creator>Hirotsu, Yosuke</creator><creator>Mochizuki, Hitoshi</creator><creator>Amemiya, Kenji</creator><creator>Oyama, Toshio</creator><creator>Uchida, Yoshinori</creator><creator>Kobayashi, Yoichi</creator><creator>Tsutsui, Toshiharu</creator><creator>Kakizaki, Yumiko</creator><creator>Miyashita, Yoshihiro</creator><creator>Omata, Masao</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8345-9551</orcidid></search><sort><creationdate>201811</creationdate><title>Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer</title><author>Iijima, Yuki ; Hirotsu, Yosuke ; Mochizuki, Hitoshi ; Amemiya, Kenji ; Oyama, Toshio ; Uchida, Yoshinori ; Kobayashi, Yoichi ; Tsutsui, Toshiharu ; Kakizaki, Yumiko ; Miyashita, Yoshihiro ; Omata, Masao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-79694a1981327a6a521dc7a68acc6abcbc59ec298c21f15522016346456051043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adenocarcinoma - drug therapy</topic><topic>Adenocarcinoma - genetics</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Carboplatin - therapeutic use</topic><topic>Cell Transformation, Neoplastic</topic><topic>Clone Cells</topic><topic>Drug Resistance, Neoplasm - genetics</topic><topic>Drug Substitution</topic><topic>ErbB Receptors - genetics</topic><topic>Etoposide - therapeutic use</topic><topic>Ex 19 del</topic><topic>Female</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - genetics</topic><topic>Middle Aged</topic><topic>Mutation - genetics</topic><topic>Neoplasm Recurrence, Local</topic><topic>Neoplasm Staging</topic><topic>Osimertinib</topic><topic>Remission Induction</topic><topic>SCLC transformation</topic><topic>Small Cell Lung Carcinoma - drug therapy</topic><topic>Small Cell Lung Carcinoma - genetics</topic><topic>T790M</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iijima, Yuki</creatorcontrib><creatorcontrib>Hirotsu, Yosuke</creatorcontrib><creatorcontrib>Mochizuki, Hitoshi</creatorcontrib><creatorcontrib>Amemiya, Kenji</creatorcontrib><creatorcontrib>Oyama, Toshio</creatorcontrib><creatorcontrib>Uchida, Yoshinori</creatorcontrib><creatorcontrib>Kobayashi, Yoichi</creatorcontrib><creatorcontrib>Tsutsui, Toshiharu</creatorcontrib><creatorcontrib>Kakizaki, Yumiko</creatorcontrib><creatorcontrib>Miyashita, Yoshihiro</creatorcontrib><creatorcontrib>Omata, Masao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical lung cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iijima, Yuki</au><au>Hirotsu, Yosuke</au><au>Mochizuki, Hitoshi</au><au>Amemiya, Kenji</au><au>Oyama, Toshio</au><au>Uchida, Yoshinori</au><au>Kobayashi, Yoichi</au><au>Tsutsui, Toshiharu</au><au>Kakizaki, Yumiko</au><au>Miyashita, Yoshihiro</au><au>Omata, Masao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer</atitle><jtitle>Clinical lung cancer</jtitle><addtitle>Clin Lung Cancer</addtitle><date>2018-11</date><risdate>2018</risdate><volume>19</volume><issue>6</issue><spage>e843</spage><epage>e847</epage><pages>e843-e847</pages><issn>1525-7304</issn><eissn>1938-0690</eissn><abstract>[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30122430</pmid><doi>10.1016/j.cllc.2018.07.002</doi><orcidid>https://orcid.org/0000-0001-8345-9551</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1525-7304 |
| ispartof | Clinical lung cancer, 2018-11, Vol.19 (6), p.e843-e847 |
| issn | 1525-7304 1938-0690 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2090331204 |
| source | ScienceDirect Freedom Collection |
| subjects | Adenocarcinoma - drug therapy Adenocarcinoma - genetics Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carboplatin - therapeutic use Cell Transformation, Neoplastic Clone Cells Drug Resistance, Neoplasm - genetics Drug Substitution ErbB Receptors - genetics Etoposide - therapeutic use Ex 19 del Female Humans Lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - genetics Middle Aged Mutation - genetics Neoplasm Recurrence, Local Neoplasm Staging Osimertinib Remission Induction SCLC transformation Small Cell Lung Carcinoma - drug therapy Small Cell Lung Carcinoma - genetics T790M |
| title | Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T07%3A47%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dynamic%20Changes%20and%20Drug-Induced%20Selection%20of%20Resistant%20Clones%20in%20a%20Patient%20With%20EGFR-Mutated%20Adenocarcinoma%20That%20Acquired%20T790M%20Mutation%20and%20Transformed%20to%20Small-Cell%20Lung%20Cancer&rft.jtitle=Clinical%20lung%20cancer&rft.au=Iijima,%20Yuki&rft.date=2018-11&rft.volume=19&rft.issue=6&rft.spage=e843&rft.epage=e847&rft.pages=e843-e847&rft.issn=1525-7304&rft.eissn=1938-0690&rft_id=info:doi/10.1016/j.cllc.2018.07.002&rft_dat=%3Cproquest_cross%3E2090331204%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-79694a1981327a6a521dc7a68acc6abcbc59ec298c21f15522016346456051043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2090331204&rft_id=info:pmid/30122430&rfr_iscdi=true |